Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Firm Income Reported for This Client
$180K
Not substituted for client expenses
Summary
ENTERON THERAPEUTICS A DIVISION OF SECANT PHARMA is an organization, based in PA. Its political footprint includes $180K in lobbying-firm income reported for this client. Lobbying activity focuses on Defense, Medical/Disease Research/Clinical Labs. Political activity spans from 2008 to 2009.